Dr Dinesh Patel, Utah’s most high profile and influential Indian American, was conferred the Willem J Kolff Lifetime Achievement Award at BioUtah’s 2013 Utah Life Science Award, the......
Sun Pharmaceutical has announced its US subsidiary, Ranbaxy Pharmaceuticals, and other partners have entered into a settlement, ending the patent litigation with drug maker Actavis over anti-acne......
Iceland's Actavis Pharma is in talks to acquire the pharma division of Pune-based Emcure Pharmaceuticals as part of its Indian business expansion plan.Emcure is among the four Indian companies......
The US Congressional committee, which is inquiring into the country's Food and Drug Administration's handling of drug-marketing approvals of India's leading drug-maker Ranbaxy, has extended its......
Close on the heels of global pharmaceutical giants, international bio-technology companies also find India an irresistible attraction, though for different reasons. If the low-cost availability of......
Ranbaxy is understood to have emerged as the sole Indian pharma entity to have moved into the next round of bidding for the generic business of Merck, even as compatriot Cipla claimed to be "very......